Denemek ALTIN - Özgür
Alkem builds case for semaglutide generics leadership
Mint Chennai
|March 23, 2026
Alkem Laboratories Ltd is positioning itself to lead India’s fast-growing weight-loss drug market
The company has launched semaglutide pen devices priced at ₹1,800 per month for the starter dose.
Alkem Laboratories Ltd is positioning itself to lead India’s fast-growing weight-loss drug market, with its generic versions of semaglutide, a well-trained medical representative network, and extensive market reach, according to Alkem’s chief executive Vikas Gupta.
The Mumbai-based firm is among the country’s top drug-makers that launched generic versions of the weight-loss drug on Saturday, a day after it lost patent exclusivity in India.
Bu hikaye Mint Chennai dergisinin March 23, 2026 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Chennai'den DAHA FAZLA HİKAYE
Mint Chennai
India's first class action hits snag as lead petitioner exits
Lead shareholder Ankit Jain has sought to exit the class action suit against Jindal Poly Films
2 mins
April 10, 2026
Mint Chennai
Panel to assess health insurers’ concerns
In an effort to improve policyholder experience and penetration of health insurance in the country, the Insurance Regulatory and Development Authority of India (Irdai) has constituted a subcommittee of the Insurance Advisory Committee.
1 mins
April 10, 2026
Mint Chennai
From access to agency: Reset the goal for women's empowerment
Increased participation in the Indian economy isn't sufficient. Women should be empowered to shape our economic outcomes
3 mins
April 10, 2026
Mint Chennai
Why Iran thinks it won the war despite huge military losses
When Iran agreed to a two-week ceasefire only hours before President Trump had vowed to unleash punishing new attacks, it was in many ways a moment of triumph for the battered regime.
4 mins
April 10, 2026
Mint Chennai
Of food, art and a drag show
A Mint guide to what's happening in and around your city
1 min
April 10, 2026
Mint Chennai
Is the US-Israel-Iran ceasefire a pause or tactical turning point?
This conflict’s trajectory will depend on whether the adversaries can resolve its structural drivers
3 mins
April 10, 2026
Mint Chennai
LNG supply woes spur India's compressed biogas push
Govt to streamline initiatives aimed at promoting biogas.
1 mins
April 10, 2026
Mint Chennai
Phoenix offers cheaper retail proxy. Real estate is the risk
Shares of The Phoenix Mills Ltd have risen 7% in the past two sessions, buoyed by its Q4FY26 business update.
1 mins
April 10, 2026
Mint Chennai
SECOND LIFE: RMG OUTFITS TRY NEW PLAYING FIELDS
Six months after real-money gaming was banned, the industry is trying to reboot.
8 mins
April 10, 2026
Mint Chennai
Govt to bar private lab tests of vaccines, biological products
India plans to restrict the testing of vaccines and specialized biological products exclusively to government-controlled laboratories to maintain quality standards, according to two government officials and documents reviewed by Mint.
1 min
April 10, 2026
Listen
Translate
Change font size